RxDoctor Payments Data

Ahmad Rafi, MD

Anesthesiology · Russellville, ARNPI 1285671487

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,970 of the $4,046 with a category attached, or 73.4%. 23 manufacturers reported payments, led by Vertiflex, Inc. at 38.5% of the total. Reporting peaked in 2019 at $2,998 and has fallen 99.2% since, to $23 in 2025. Among anesthesiology clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,046in general payments, 2019–2025

Across 82 payments — averaging $49.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertiflex, Inc.$2K
  • Stimwave Technologies Incorporated$671
  • Vertos Medical, Inc.$369
  • Boston Scientific$299
  • Medtronic$231
  • Nevro Corp.$224
  • plus $693 from 17 others

What the payments were for

  • Travel & lodging$1,07727%
  • Food & beverage$2,97073%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,046 in reported general payments places this provider in the 95th percentile of 300 anesthesiology providers in Arkansas.

See all anesthesiology providers in Arkansas

Medicare billing

Part B allowed, 2024
$332,988
Medicare patients
235
Services billed
2,454

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,325$64,559
BelbucaBuprenorphine Hcl26$17,276
Gabapentin1,159$15,419
Pregabalin541$11,891
Buprenorphine56$11,877
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen355$10,313
Tizanidine Hcl707$6,612
Naloxone Hcl80$5,765
Acetaminophen-CodeineAcetaminophen With Codeine277$5,052
Methocarbamol414$3,829
Oxycodone Hcl248$3,736
Tramadol Hcl530$3,709
Cyclobenzaprine Hcl385$3,424
Duloxetine Hcl271$3,353
Morphine Sulfate ErMorphine Sulfate118$2,763

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$11$17,27626 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 300 anesthesiology providers in Arkansas.

Other anesthesiology in Russellville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →